Biosimilar drugs a boon to be applauded as they provide equivalent treatment at – sometimes – half the price

19 July 2019 - The fastest-growing segment of our health-care system is prescription drugs – now constituting the second-highest category ...

Read more →

Canada warns U.S. against drug import plans, citing shortage concerns

18 July 2019 - Canada opposes any U.S. plans to buy Canadian prescription drugs that might threaten the country’s drug supply ...

Read more →

In praise of studies that use more than one generic preference-based measure

12 July 2019 - Generic preference-based measures of health-related quality of life are widely used as outcome measures in cost-effectiveness and ...

Read more →

Canada’s labour leaders encourage premiers to embrace universal pharmacare

10 July 2019 - The presidents of federations of labour from across the country are in Saskatoon during the Council ...

Read more →

New committee brings diverse patient, family, and caregiver voices to CADTH

10 July 2019 - Following a nationwide call for nominations, CADTH is pleased to announce the membership of its new ...

Read more →

Life-changing drug Spinraza still not covered for many Canadians with spinal muscular atrophy

4 July 2019 - For several hundred Canadians with spinal muscular atrophy, Spinraza is a drug that means the difference ...

Read more →

Canada’s ‘Pharmacare’ idea will face the same obstacles as Obamacare

27 June 2019 - Canadians have long viewed their single payer health care system with a near-religious reverence, largely because ...

Read more →

Pharmacare in Canada remains an idealistic pitch, without a realistic plan

26 June 2019 - We still haven't figured out how to make health care truly universal. ...

Read more →

Forcing patients to switch to biosimilars puts them in uncharted waters

23 June 2019 - On May 27, the B.C. government announced a policy that will forcibly switch thousands of patients, ...

Read more →

Advisory Council supports biosimilars in call for universal public drug coverage in Canada

17 June 2019 - A Canadian advisory council is recommending the use of biosimilars in a final report that lays ...

Read more →

Canada already has a pharmacare system — and it's working

17 June 2019 - Why blow up a system that is mostly working and take on billions in new spending when ...

Read more →

Patient with rare disease pleads for life-saving drug funding

17 June 2019 - 'You wait five years for the diagnosis, then they tell you, 'We're not going to fund you.' ...

Read more →

Ontario grants broader access to Spinraza (nusinersen) for patients living with spinal muscular atrophy

13 June 2019 - Ontario joins Saskatchewan and Quebec to give patients with spinal muscular atrophy broader access to Spinraza. ...

Read more →

Canada should have universal, single-payer public pharmacare, says advisory council

12 June 2019 - Canada should have a national pharmacare program that is universal, single payer and public, says an ...

Read more →

Ford government to fund Spinraza, world’s most expensive drug - with age caps

12 June 2019 - The Ford government today announced it will be covering the cost of the drug Spinraza for ...

Read more →